- Report
- March 2023
- 190 Pages
Germany
From €2266EUR$2,490USD£1,925GBP
- Report
- March 2023
- 130 Pages
Japan
From €2266EUR$2,490USD£1,925GBP
- Report
- March 2023
- 190 Pages
Switzerland
From €2266EUR$2,490USD£1,925GBP
- Report
- February 2023
- 130 Pages
France
From €2266EUR$2,490USD£1,925GBP
- Report
- February 2023
- 130 Pages
Canada
From €2266EUR$2,490USD£1,925GBP
- Report
- February 2023
- 120 Pages
Israel
From €2266EUR$2,490USD£1,925GBP
- Report
- September 2020
- 168 Pages
Netherlands
From €1811EUR$1,990USD£1,538GBP
- Report
- April 2021
China
From €2366EUR$2,600USD£2,010GBP
- Report
- November 2018
- 30 Pages
China
From €2002EUR$2,200USD£1,701GBP
- Report
- January 2024
- 150 Pages
Global
From €4414EUR$4,850USD£3,749GBP
- Report
- January 2024
- 315 Pages
Global
From €3186EUR$3,500USD£2,706GBP
- Report
- October 2021
- 180 Pages
United States
From €2275EUR$2,500USD£1,933GBP
- Report
- October 2021
- 45 Pages
United States
From €901EUR$990USD£765GBP
- Report
- March 2019
- 80 Pages
United States
From €1174EUR$1,290USD£997GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 134 Pages
Germany
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 133 Pages
Russia
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 131 Pages
China
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 138 Pages
Japan
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €2730EUR$2,999USD£2,318GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more